Skip to main content
Clinical Trials/NL-OMON48180
NL-OMON48180
Recruiting
Not Applicable

Single-stage bone-anchored hearing implant surgery in the pediatric population using the BHX implant - Single-stage surgery using the BHX implant

Radboud Universitair Medisch Centrum0 sites22 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
conductive hearing loss
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
22
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age 4\-9 years
  • \- Indication for percutaneous bone\-anchored hearing implant surgery with a BHX
  • \- Insertion using the linear incision techniqueControl group (historical)
  • \- Children who underwent implantation of a wide diameter implant using
  • two\-stage surgery between 2012 and 2018 at the Radboudumc
  • \- Age 4\-9 at the time of surgery

Exclusion Criteria

  • 1\. Inability to show up at all follow\-up visits
  • 2\. Patients undergoing re\-implantation
  • 3\. Diseases, syndromes or treatments known to compromise the bone quality at
  • the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
  • 4\. Insufficient bone thickness \<\=1mm, since conversion to two\-stage surgery will
  • be advocatedControl group
  • 1\. Follow\-up duration less than 1 year.
  • 2\. Diseases, syndromes or treatments known to compromise the bone quality at
  • the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus (at moment
  • of implantation)

Outcomes

Primary Outcomes

Not specified

Similar Trials